Table 1. Distribution of dose length product values.
Percutaneous destruction of | N | Dose length product (mGy·cm) | ||||||
---|---|---|---|---|---|---|---|---|
Minimum | Q1 | Median | Q3 | Maximum | Average | SD | ||
Bone lesions | 150 | 52 | 339.0 | 637.1 | 1,316.3 | 6,142.0 | 991.6 | 979.0 |
Abdominal tumors | 463 | 112 | 1,012.8 | 1,545.4 | 2,479.0 | 16,455.0 | 2,130.7 | 2,051.8 |
Thoracic tumors | 209 | 75 | 437.0 | 687.7 | 1,112.2 | 3,157.1 | 825.2 | 545.4 |
Q1, first quartile; Q3, third quartile; N, number of patients; SD, standard deviation.